Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial
Kim et al., Frontiers in Medicine, doi:10.3389/fmed.2023.1095828
https://c19early.org/kim9.html